Left with unanswered questions,

House E&C Might Hold Another Rx-Price Hearing Soon

By John Wilkerson / December 13, 2017 at 9:45 PM
Representatives of the drug-distribution sectors argued over the causes of drug prices at a House Energy & Commerce health subcommittee hearing Wednesday (Dec. 13), but lawmakers were left with unanswered questions and the committee Chair Greg Walden (R-OR) said the subcommittee will likely hold another hearing on drug prices early next year. Insulin prices became the example of rising drug prices on which lawmakers based their questions for a segment of the hearing. Walden asked how insulin went from a...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.